直接抗丙肝病毒新药中的生殖毒性研究评价
发布时间：2018-08-04 12:45
【摘要】：随着对丙肝病毒(HCV)的研究深入,直接抗病毒治疗药物(DAA)逐渐成为慢性丙型肝炎(CHC)治疗领域的关注焦点。本文通过检索FDA药品管理机构公开的药品信息,对已上市DAA药物的生殖毒性试验信息进行汇总和分析,以期丰富对DAA药物生殖毒性的了解,有助于临床用药的利弊权衡。
[Abstract]:With the further study of hepatitis C virus (HCV), the direct antiviral drug (DAA) has gradually become the focus in the field of (CHC) treatment of chronic hepatitis C. In this paper, the information of reproductive toxicity test of listed DAA drugs was collected and analyzed by searching the drug information published by FDA drug administration organization, in order to enrich the understanding of reproductive toxicity of DAA drugs and to help weigh the advantages and disadvantages of clinical drug use.
【作者单位】： 国家食品药品监督管理总局药品审评中心;
【分类号】：R965
[Abstract]:With the further study of hepatitis C virus (HCV), the direct antiviral drug (DAA) has gradually become the focus in the field of (CHC) treatment of chronic hepatitis C. In this paper, the information of reproductive toxicity test of listed DAA drugs was collected and analyzed by searching the drug information published by FDA drug administration organization, in order to enrich the understanding of reproductive toxicity of DAA drugs and to help weigh the advantages and disadvantages of clinical drug use.
【作者单位】： 国家食品药品监督管理总局药品审评中心;
【分类号】：R965
【相似文献】
相关期刊论文 前10条
1 孙祖越;闫晗;;生殖毒性研究进展[J];毒理学杂志;2007年05期
2 王海莲;张晓乐;刘芳;徐燕侠;闫素英;;生殖毒性药品安全使用干预研究[J];中国药学杂志;2012年24期
3 李煌元 ,吴思英;镉的雌性性腺生殖毒性研究现状[J];中国公共卫生;2002年03期
4 王正容,罗丽娅,刘萍,钱文t，
本文编号：2163925
本文链接：https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2163925.html
最近更新
教材专著
